Author

Mark Walker

Newcastle UniversityORCID 0000-0002-2526-9810Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:GWAS / association mapping· 2 Assay:metabolomics· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Adem Y. DawediD· 3 shared Andrea MariiD· 3 shared Andrew Tym HattersleyiD· 3 shared Angus G. JonesiD· 3 shared Anubha MahajaniD· 3 shared Giuseppe Nicola GiordanoiD· 3 shared Hartmut Ruetten· 3 shared Hugo FitipaldiiD· 3 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenetic & Genomic Medicine

Adem Y. DawedORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genetic & Genomic MedicineNature CommunicationsPeer-reviewedAug 21, 2023

Genetic analysis of blood molecular phenotypes reveals regulatory networks affecting complex traits: a DIRECT study.

Andrew Anand Brown, Juan J. Fernandez-Tajes, Mun‐Gwan Hong…·Ulrik Plesner Jacobsen

The paper identifies shared genetic regulation across mRNA, proteins, and metabolites in blood, revealing networks and mediators of GWAS variants.

44 citationstop 2%

humanbulk RNA-seq

𝕏 PostBluesky

Genetic & Genomic MedicineThe Lancet Diabetes & EndocrinologyPeer-reviewedDec 15, 2022

Pharmacogenomics of GLP-1 Receptor Agonists: A genome-wide analysis of observational data and large randomized controlled trials

Adem Y. Dawed, Andrea Mari, Andrew Anand Brown…·A. Jonsson

This study identifies genetic variants associated with glycaemic response to GLP-1 receptor agonists using observational and trial data, finding variants in GLP-1R and ARRB1 linked to HbA1c reduction.

137 citationstop 1%

humanGWAS summary statistics

𝕏 PostBluesky

Genetic & Genomic MedicinePLoS MedicinePeer-reviewedJun 19, 2020

Predicting and elucidating the etiology of fatty liver disease using a machine learning-based approach: an IMI DIRECT study

Naeimeh Atabaki‐Pasdar, Mattias Ohlsson, Ana Viñuela…·Paul W. Franks

This study develops machine learning models to predict liver fat content using multi-omic and clinical data from NAFLD patients, achieving higher accuracy than existing tools.

97 citationstop 1%

humanmetabolomics

𝕏 PostBluesky